BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2478438)

  • 1. Modulation of the antigenicity of amylase in cervical glandular atypia, adenocarcinoma in situ and invasive adenocarcinoma.
    Griffin NR; Wells M; Fox H
    Histopathology; 1989 Sep; 15(3):267-79. PubMed ID: 2478438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and localization of amylase in normal and malignant glands of the endometrium and endocervix.
    Lee YS; Raju GC
    J Pathol; 1988 Jul; 155(3):201-5. PubMed ID: 2457671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion?
    Brown LJ; Wells M
    J Clin Pathol; 1986 Jan; 39(1):22-8. PubMed ID: 3950029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist?
    Goldstein NS; Ahmad E; Hussain M; Hankin RC; Perez-Reyes N
    Am J Clin Pathol; 1998 Aug; 110(2):200-9. PubMed ID: 9704619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocervical glandular atypia and adenocarcinoma: a correlation of cytology and histology.
    Nasu I; Meurer W; Fu YS
    Int J Gynecol Pathol; 1993 Jul; 12(3):208-18. PubMed ID: 8344758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Mikami Y; Minamiguchi S; Teramoto N; Nagura M; Haga H; Konishi I
    Pathol Res Pract; 2013 Mar; 209(3):173-8. PubMed ID: 23391777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust expression of EZH2 in endocervical neoplastic lesions.
    Makk E; Bálint L; Cifra J; Tornóczky T; Oszter A; Tóth A; Kálmán E; Kovács K
    Virchows Arch; 2019 Jul; 475(1):95-104. PubMed ID: 30903272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal deviation adenocarcinoma (adenoma malignum) of the endocervix: a histochemical and immunohistochemical study of two cases.
    Bulmer JN; Griffin NR; Bates C; Kingston RE; Wells M
    Gynecol Oncol; 1990 Jan; 36(1):139-46. PubMed ID: 1688543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of adenocarcinoma in situ arising in lobular endocervical glandular hyperplasia indicating localization of mucin on the cluster surface as an early cytological finding of malignant transformation.
    Okuyama R; Hashimoto H; Miura T; Sugita M; Arai M; Tsunoda H; Sasajima Y; Horiuchi H
    Diagn Cytopathol; 2017 Sep; 45(9):842-847. PubMed ID: 28449203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
    Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
    Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma.
    Ali-Fehmi R; Qureshi F; Lawrence WD; Jacques SM
    Int J Gynecol Pathol; 2004 Jan; 23(1):1-6. PubMed ID: 14668542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
    Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H
    Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of glutathione S-transferase in preneoplastic and neoplastic lesions of the human uterine cervix.
    Maguire NC; Drozd K; Luff RD; Kantor RR
    Acta Cytol; 1991; 35(1):94-9. PubMed ID: 1994644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocervical glandular atypia in Papanicolaou smears.
    Goff BA; Atanasoff P; Brown E; Muntz HG; Bell DA; Rice LW
    Obstet Gynecol; 1992 Jan; 79(1):101-4. PubMed ID: 1727566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of glands to thick-wall blood vessels as a marker of invasion in endocervical adenocarcinoma.
    Wheeler DT; Kurman RJ
    Int J Gynecol Pathol; 2005 Apr; 24(2):125-30. PubMed ID: 15782068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer].
    Ueda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1401-8. PubMed ID: 2685140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
    Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
    Jaworski RC
    Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining.
    Mikami Y; Kiyokawa T; Moriya T; Sasano H
    Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.